A microfluidic-based neurotoxin concentration gradient for the generation of an in vitro model of Parkinson’s disease

• Published in: Biomicrofluidics Vol. 5; no. 2; pp. 022214 - 022214-14
• Main Authors: Seidi, Azadeh, Kaji, Hirokazu, Annabi, Nasim, Ostrovidov, Serge, Ramalingam, Murugan, Khademhosseini, Ali
• Format: Journal Article
• Language: English
• Published: United States American Institute of Physics 01.06.2011
• Subjects: Special Topic: Microfluidics in Cell Biology and Tissue Engineering (Guest Editor: Ali Khademhosseini)
• ISSN: 1932-1058; 1932-1058
• DOI: 10.1063/1.3580756

In this study, we developed a miniaturized microfluidic-based high-throughput cell toxicity assay to create an in vitro model of Parkinson’s disease (PD). In particular, we generated concentration gradients of 6-hydroxydopamine (6-OHDA) to trigger a process of neuronal apoptosis in pheochromocytoma PC12 neuronal cell line. PC12 cells were cultured in a microfluidic channel, and a concentration gradient of 6-OHDA was generated in the channel by using a back and forth movement of the fluid flow. Cellular apoptosis was then analyzed along the channel. The results indicate that at low concentrations of 6-OHDA along the gradient (i.e., approximately less than 260   μ M ), the neuronal death in the channel was mainly induced by apoptosis, while at higher concentrations, 6-OHDA induced neuronal death mainly through necrosis. Thus, this concentration appears to be useful for creating an in vitro model of PD by inducing the highest level of apoptosis in PC12 cells. As microfluidic systems are advantageous in a range of properties such as throughput and lower use of reagents, they may provide a useful approach for generating in vitro models of disease for drug discovery applications.